{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:39Z","timestamp":1793306019258,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40261-014-0212-3","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T08:24:12Z","timestamp":1403166252000},"page":"587-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":180,"title":["Preliminary, Open-Label, Pilot Study of Add-On Oral \u03949-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder"],"prefix":"10.1007","volume":"34","author":[{"given":"Pablo","family":"Roitman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Cooper-Kazaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieh","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,17]]},"reference":[{"issue":"1 Suppl 1","key":"212_CR1","first-page":"25","volume":"14","author":"DJ Stein","year":"2009","unstructured":"Stein DJ, Ipser J, McAnda N. Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines. CNS Spectr. 2009;14(1 Suppl 1):25\u201331.","journal-title":"CNS Spectr"},{"issue":"3","key":"212_CR2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1037\/a0021945","volume":"25","author":"MO Bonn-Miller","year":"2011","unstructured":"Bonn-Miller MO, Vujanovic AA, Drescher KD. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol Addict Behav. 2011;25(3):485\u201391.","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"212_CR3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389\u2013462.","journal-title":"Pharmacol Rev"},{"issue":"7\u20138","key":"212_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/dta.1377","volume":"4","author":"T Passie","year":"2012","unstructured":"Passie T, Emrich HM, Karst M, Brandt SD, Halpern JH. Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. Drug Test Anal. 2012;4(7\u20138):649\u201359.","journal-title":"Drug Test Anal"},{"issue":"5","key":"212_CR5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1176\/appi.ajp.2010.09121762","volume":"167","author":"JM Pierre","year":"2010","unstructured":"Pierre JM. Psychosis associated with medical marijuana: risk vs. benefits of medicinal cannabis use. Am J Psychiatry. 2010;167(5):598\u20139.","journal-title":"Am J Psychiatry"},{"key":"212_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1300\/J175v01n01_03","volume":"1","author":"RE Musty","year":"2001","unstructured":"Musty RE, Rossi R. Effects of smoked Cannabis and oral delta-9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy: a review of state clinical trials. J Cannabis Therapy. 2001;1:30.","journal-title":"J Cannabis Therapy"},{"issue":"7","key":"212_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","volume":"24","author":"JA Crippa","year":"2009","unstructured":"Crippa JA, Zuardi AW, Martin-Santos R, Bhattacharyya S, Atakan Z, McGuire P, et al. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol. 2009;24(7):515\u201323.","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"212_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QAI.0b013e31811ed205","volume":"45","author":"M Haney","year":"2007","unstructured":"Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, et al. Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep. J Acquir Immune Defic Syndr. 2007;45(5):545\u201354.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"212_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","volume":"15","author":"GA Fraser","year":"2009","unstructured":"Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009;15(1):84\u20138.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"212_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","volume":"46","author":"GR Greer","year":"2014","unstructured":"Greer GR, Grob CS, Halberstadt AL. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. J Psychoact Drugs. 2014;46(1):73\u20137.","journal-title":"J Psychoact Drugs"},{"issue":"6897","key":"212_CR11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","volume":"418","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002;418(6897):530\u20134.","journal-title":"Nature"},{"key":"212_CR12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2012.06.063","volume":"64","author":"CA Rabinak","year":"2013","unstructured":"Rabinak CA, Angstadt M, Sripada CS, Abelson JL, Liberzon I, Milad MR, et al. Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology. 2013;64:396\u2013402.","journal-title":"Neuropharmacology"},{"issue":"9","key":"212_CR13","first-page":"6","volume":"18","author":"A Neumeister","year":"2013","unstructured":"Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, et al. Elevated brain cannabinoid CB receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 2013;18(9):6.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"212_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jts.2490080106","volume":"8","author":"DD Blake","year":"1995","unstructured":"Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8(1):75\u201390.","journal-title":"J Trauma Stress"},{"key":"212_CR15","doi-asserted-by":"crossref","unstructured":"Guy GW. The Clinical Global Impression Scale. In: ECDEU assessment manual for psychopharmacology\u2013revised. Bethesda; US Department of Health, Education and Welfare; 1976: pp 218\u2013222.","DOI":"10.1037\/e591322011-001"},{"issue":"2","key":"212_CR16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193\u2013213.","journal-title":"Psychiatry Res"},{"issue":"2","key":"212_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0887-6185(02)00093-2","volume":"16","author":"B Krakow","year":"2002","unstructured":"Krakow B. Nightmare frequency in sexual assault survivors with PTSD. J Anxiety Disord. 2002;16(2):175\u201390.","journal-title":"J Anxiety Disord"},{"issue":"4","key":"212_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1023\/A:1007854015481","volume":"13","author":"B Krakow","year":"2000","unstructured":"Krakow B, Hollifield M, Schrader R, Koss M, Tandberg D, Lauriello J, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. J Trauma Stress. 2000;13(4):589\u2013609.","journal-title":"J Trauma Stress"},{"key":"212_CR19","unstructured":"Guy GW. A phase 1, double blind, three-way crossover study to assess the pharmacokinetic profile of cannabis based medicine extract (CBME) administered sublingually in variant cannabinoid ratios in normal healthy male volunteers. J Cannabis Ther 2003;3:31."},{"issue":"5","key":"212_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.ijg.0000212260.04488.60","volume":"15","author":"I Tomida","year":"2006","unstructured":"Tomida I, Azuara-Blanco A, House H, Flint M, Pertwee RG, Robson PJ. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study. J Glaucoma. 2006;15(5):349\u201353.","journal-title":"J Glaucoma"},{"issue":"3","key":"212_CR21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15360280802251215","volume":"22","author":"S Haroutiunian","year":"2008","unstructured":"Haroutiunian S, Rosen G, Shouval R, Davidson E. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain. J Pain Palliat Care Pharmacother. 2008;22(3):213\u20137.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"29\u201330","key":"212_CR22","first-page":"495","volume":"109","author":"F Grotenhermen","year":"2012","unstructured":"Grotenhermen F, Muller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Deutsches Arzteblatt Int. 2012;109(29\u201330):495\u2013501.","journal-title":"Deutsches Arzteblatt Int"},{"issue":"136","key":"212_CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugalcdep.2013.12.008","volume":"1","author":"MO Bonn-Miller","year":"2014","unstructured":"Bonn-Miller MO, Babson KA, Vandrey R. Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. Drug Alcohol Depend. 2014;1(136):162\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"212_CR24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.smrv.2007.12.004","volume":"12","author":"T Schierenbeck","year":"2008","unstructured":"Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev. 2008;12(5):381\u20139.","journal-title":"Sleep Med Rev"},{"issue":"3","key":"212_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/ajp.153.3.369","volume":"153","author":"JD Bremner","year":"1996","unstructured":"Bremner JD, Southwick SM, Darnell A, Charney DS. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry. 1996;153(3):369\u201375.","journal-title":"Am J Psychiatry"},{"issue":"1293","key":"212_CR26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.brainres.2009.03.030","volume":"26","author":"RJ Ursano","year":"2009","unstructured":"Ursano RJ, Zhang L, Li H, Johnson L, Carlton J, Fullerton CS, et al. PTSD and traumatic stress from gene to community and bench to bedside. Brain Res. 2009;26(1293):2\u201312.","journal-title":"Brain Res"},{"issue":"4","key":"212_CR27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","volume":"124","author":"CH Ashton","year":"2011","unstructured":"Ashton CH, Moore PB. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand. 2011;124(4):250\u201361.","journal-title":"Acta Psychiatr Scand"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-014-0212-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0212-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T18:10:53Z","timestamp":1565547053000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-014-0212-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,17]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1007\/s40261-014-0212-3","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,17]]}}}